Literature DB >> 14577322

[Congenital middle ear cholesteatoma: experience in 48 cases].

Hiromi Kojima1, Hidemi Miyazaki, Yasuhiro Tanaka, Masanori Shiwa, Yoshio Honda, Hiroshi Moriyama.   

Abstract

We studied 48 patients (48 ears) with congenital cholesteatoma who underwent surgery at our department from 1979 to 2000, and investigated symptoms at initial onset, tympanic membrane findings, cholesteatoma configuration and site, type of surgical procedure, and surgical outcome. Patients were from 2 to 62 years old (mean: 16.7 years), with 60.4% aged 15 years or younger. The symptom at initial onset was hearing loss in most (58.2%). Hearing loss was the main symptom in all with open type cholesteatoma, and most of these patients had normal tympanic membrane findings. The cholesteatoma was located mainly in the superior posterior portion of the tympanic cavity in many patients. The site of involvement was the tympanic cavity in 12 (25.0%), mastoid cavity in 2 (4.2%) and the petrous apex in 1 (2.1%). In many of (31 ears, 64.6%), the cholesteatoma was advanced and extended from the tympanic cavity to the mastoid antrum. For 23 of the 48 ears, treatment was completed in one operation. The remaining 25 ears required staged surgery. Loss of the structure of the upper part of the stapes was seen in 58.3% of patients, so most underwent type IV ossiculoplasty, with types III and I next most common.

Entities:  

Mesh:

Year:  2003        PMID: 14577322     DOI: 10.3950/jibiinkoka.106.856

Source DB:  PubMed          Journal:  Nihon Jibiinkoka Gakkai Kaiho        ISSN: 0030-6622


  2 in total

1.  Non-classical presentation of congenital cholesteatoma.

Authors:  V R Mahanta; F J Uddin; S Mohan; J F Sharp
Journal:  Ann R Coll Surg Engl       Date:  2007-03       Impact factor: 1.891

2.  Atypical presentation of congenital cholesteatoma in an adult case with good hearing result.

Authors:  Fevzi Solmaz; Davut Akduman; Mehmet Haksever; Ercan Gündoğdu; Atilla Mescioğlu
Journal:  Ann Med Surg (Lond)       Date:  2015-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.